Mican Technologies
Kyoto, JP · 3 known investors
Find your way into Mican Technologies
38 people in our graph share verified history with the Mican Technologies team — schools, employers, funds. One of them is your warm intro.
Takehiko Sawabeunlockedknows Kazuhisa Fushihara · together at Graduate School of Management, Globis University (overlapped)
×2knows the team · via Graduate School of Management, Globis University
×5knows the team · via GLOBIS University - Graduate School of Management
×3knows the team · via Tohoku University
knows the team · via Tokyo University of Science
MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.
Founders & leadership
KM
Kazuo Miyazakiin代表取締役CEO (Representative Director & CEO)Kazuo Miyazaki is founder and CEO of MiCAN Technologies, with over eight years of experience in drug discovery and safety testing using stem cell technologies. His background includes work in medicinal chemistry, drug discovery, and stem cell research.
KF
Kazuhisa Fushiharain取締役CFO (Director & CFO)Kazuhisa Fushihara studied biochemistry at Tohoku University and enzyme characterization, then worked in R&D at Sumitomo Rubber developing printing blankets, golf ball materials, tire compounds, and sensors. He joined MiCAN Technologies as COO and CFO, managing business development, organizational development, and fundraising, and currently leads the company's safety testing business operations from Heidelberg; he holds 88 patents in his technical capacity.
Board
YN
Yasuhiro Natsume取締役 (Director)
Investors · 3
Frequently asked questions
- What does Mican Technologies do?
- MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.
- Who are Mican Technologies's investors?
- Mican Technologies's investors include Kobe University Capital, OSAKA University Venture Capital, UntroD Capital.
- Where is Mican Technologies headquartered?
- Mican Technologies is headquartered in Kyoto, JP.